Literature DB >> 20580125

Outbreak of carbapenem-resistant Acinetobacter baumannii among non-burn patients in a burn intensive care unit.

R K Gulati, J Choudhuri, C Fulton, J D Chan, H L Evans, J B Lynch, T H Dellit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20580125      PMCID： PMC4582015          DOI： 10.1016/j.jhin.2010.04.005

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  8 in total

1.  Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit.

Authors:  S H Wang; W H Sheng; Y Y Chang; L H Wang; H C Lin; M L Chen; H J Pan; W J Ko; S C Chang; F Y Lin
Journal:  J Hosp Infect       Date:  2003-02       Impact factor: 3.926

2.  Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.

Authors:  E G Playford; J C Craig; J R Iredell
Journal:  J Hosp Infect       Date:  2007-01-23       Impact factor: 3.926

3.  Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit.

Authors:  S A Roberts; R Findlay; S D Lang
Journal:  J Hosp Infect       Date:  2001-07       Impact factor: 3.926

4.  Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Authors:  Rebecca H Sunenshine; Marc-Oliver Wright; Lisa L Maragakis; Anthony D Harris; Xiaoyan Song; Joan Hebden; Sara E Cosgrove; Ashley Anderson; Jennifer Carnell; Daniel B Jernigan; David G Kleinbaum; Trish M Perl; Harold C Standiford; Arjun Srinivasan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

Review 5.  Acinetobacter outbreaks, 1977-2000.

Authors:  Maria Virginia Villegas; Alan I Hartstein
Journal:  Infect Control Hosp Epidemiol       Date:  2003-04       Impact factor: 3.254

6.  Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.

Authors:  Petros Kopterides; Patra K Koletsi; Argyris Michalopoulos; Matthew E Falagas
Journal:  Int J Antimicrob Agents       Date:  2007-09-11       Impact factor: 5.283

Review 7.  Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.

Authors:  Lisa L Maragakis; Trish M Perl
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

8.  Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.

Authors:  Nan-Yao Lee; Hsin-Chun Lee; Nai-Ying Ko; Chia-Ming Chang; Hsin-I Shih; Chi-Jung Wu; Wen-Chien Ko
Journal:  Infect Control Hosp Epidemiol       Date:  2007-05-14       Impact factor: 3.254
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.